Efficacy and safety of eculizumab in atypical hemolytic uremic syndrome from 2-year extensions of phase 2 studies

2015412 citationsJournal Articlegreen Open Access

Authors

Good health and well-being

Published in: Kidney International

Volume 87, Issue 5, pp. 1061-1073

Field-Weighted Citation Impact: 22.00